Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126524313 | 12652431 | 3 | F | 20160829 | 20160815 | 20160902 | PER | US-PFIZER INC-2016379952 | PFIZER | 61.00 | YR | F | Y | 84.35000 | KG | 20160902 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126524313 | 12652431 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 3X/DAY | 21446 | 50 | MG | CAPSULE, HARD | TID | ||||||
| 126524313 | 12652431 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, DAILY | 21446 | 300 | MG | CAPSULE, HARD | |||||||
| 126524313 | 12652431 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | UNK | U | 20235 | ||||||||||
| 126524313 | 12652431 | 4 | SS | SKELAXIN | METAXALONE | 1 | UNK | U | 13217 | TABLET | |||||||||
| 126524313 | 12652431 | 5 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | UNK | 20702 | |||||||||||
| 126524313 | 12652431 | 6 | SS | PROMETHAZINE HCL | PROMETHAZINE HYDROCHLORIDE | 1 | 25 MG, AS NEEDED | 40372 | 25 | MG | |||||||||
| 126524313 | 12652431 | 7 | SS | ADVIL | IBUPROFEN | 1 | UNK | U | 18989 | ||||||||||
| 126524313 | 12652431 | 8 | SS | MOTRIN | IBUPROFEN | 1 | U | 18989 | |||||||||||
| 126524313 | 12652431 | 9 | SS | CELEBREX | CELECOXIB | 1 | UNK | U | 20998 | CAPSULE, HARD | |||||||||
| 126524313 | 12652431 | 10 | SS | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | UNK | U | 22396 | SOLUTION FOR INJECTION | |||||||||
| 126524313 | 12652431 | 11 | SS | GLIPIZIDE. | GLIPIZIDE | 1 | 10 MG, 2X/DAY | 17783 | 10 | MG | BID | ||||||||
| 126524313 | 12652431 | 12 | SS | DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | 1 | 180 MG, 1X/DAY | 74941 | 180 | MG | QD | ||||||||
| 126524313 | 12652431 | 13 | C | TIZANIDINE HCL | TIZANIDINE HYDROCHLORIDE | 1 | UNK UNK, AS NEEDED [2 MG; 1-2 AS NEEDED] | 0 | |||||||||||
| 126524313 | 12652431 | 14 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | BID | ||||||||
| 126524313 | 12652431 | 15 | C | LISINOPRIL HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | UNK UNK, 1X/DAY [LISINOPRIL-20]/ [HYDROCHLOROTHIAZIDE-25] | 0 | QD | ||||||||||
| 126524313 | 12652431 | 16 | C | ROPINIROLE. | ROPINIROLE | 1 | 2 MG, 1X/DAY [1 MG; 2 AT NIGHT] | 0 | 2 | MG | QD | ||||||||
| 126524313 | 12652431 | 17 | C | BUPROPION. | BUPROPION | 1 | 150 MG, 2X/DAY | 0 | 150 | MG | BID | ||||||||
| 126524313 | 12652431 | 18 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | UNK UNK, 3X/DAY [HYDROCODONE BITARTRATE-5]/[PARACETAMOL-325] | 0 | TID | ||||||||||
| 126524313 | 12652431 | 19 | C | TOUJEO | INSULIN GLARGINE | 1 | 40 IU, 1X/DAY | 0 | 40 | IU | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126524313 | 12652431 | 1 | Diabetic neuropathy |
| 126524313 | 12652431 | 4 | Paralysis |
| 126524313 | 12652431 | 7 | Inflammation |
| 126524313 | 12652431 | 8 | Inflammation |
| 126524313 | 12652431 | 9 | Inflammation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126524313 | 12652431 | Asthenia | |
| 126524313 | 12652431 | Dizziness | |
| 126524313 | 12652431 | Drug ineffective | |
| 126524313 | 12652431 | Insomnia | |
| 126524313 | 12652431 | Nausea | |
| 126524313 | 12652431 | Night sweats |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |